The macroheterogeneity of recombinant human interferon-gamma produced by Chinese-hamster ovary cells is affected by the protein and lipid content of the culture medium.
The culture environment exerts a major effect on the glycosylation pattern of recombinant human interferon-gamma (IFN-gamma) produced by Chinese-hamster ovary (CHO) cells. The recombinant IFN-gamma is heterogeneous and consists of a mixture of fully (2N), partially (1N) and non-glycosylated (0N) glycoforms, and throughout batch cultures there is a decline in the proportion of fully glycosylated IFN-gamma. Glucose and glutamine, nutrients that are depleted early in such cultures, were prima facie candidates for causing such a shift in glycoform profile. Batch feeding of these nutrients did not prevent the decline in 2N glycoform, but the glycosylation pattern of IFN-gamma was affected by the initial glutamine concentration in the culture. Under different serum-free environments the extent of IFN-gamma glycosylation was affected by (1) the concentration of BSA, (2) the quality of BSA, (3) the lipid composition of the culture medium and (4) the presence of surfactants. Moreover, the inclusion of serum in cultures caused changes in the molecular masses of the major glycoforms, that was indicative of cleavage of the core polypeptide. The results reported emphasize the necessity of considering the effects of culture media on product quality as well as on product quantity during process optimization.
Castro
P M
PM
Research School of Biosciences, Biological Laboratory, University of Kent, Canterbury, U.K.
Ison
A P
AP
Hayter
P M
PM
Bull
A T
AT
D000818:Animals; D016466:CHO Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D016895:Culture Media, Serum-Free; D004591:Electrophoresis, Polyacrylamide Gel; D005947:Glucose / Q000494:pharmacology; D005973:Glutamine / Q000494:pharmacology; D006031:Glycosylation; D006801:Humans; D007371:Interferon-gamma / Q000737:chemistry / Q000378:metabolism*; D008055:Lipids / Q000494:pharmacology; D008970:Molecular Weight; D009154:Mutation / Q000235:genetics; D010957:Plasmids / Q000235:genetics; D011401:Promoter Regions, Genetic; D011994:Recombinant Proteins; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology
D016895:Culture Media, Serum-Free; D008055:Lipids; D011994:Recombinant Proteins; D013501:Surface-Active Agents; D005973:Glutamine; D012710:Serum Albumin, Bovine; D007371:Interferon-gamma; D005947:Glucose